{"Q": 8, "answer": "yes", "rationale": "The segment describes vaccine development capability: 'late-stage trial would likely focus on safety and immune response'.", "method": "llm_batch", "batch_id": "batch_8_17712", "batch_size": 200, "batch_pos": 65, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
